Oral nutritional supplements for gastric cancer – the review of current evidence
https://doi.org/10.17709/2409-2231-2021-8-1-5
Abstract
The analysis of the current evidence base concerning the use of oral nutritional supplements (ONS) in gastric cancer (GC) has been made. Databases of scientific information eLIBRARY.ru and PubMed were used. Emphasis is placed on randomized clinical trials and meta‑analyses. The application of ONS is suggested for all patients who undergo to surgical treatment for GC. Its use allows increasing protein and energy consumption, improving the quality of life, some parameters of nutritional status and immunity (albumin, blood lymphocytes etc.). In patients with severe malnutrition (SM) ONS can significantly reduce the incidence of clinically important postoperative complications. The use of this type of medical nutrition in the first 5 days after surgery is safe and does not increase the rate of anastomotic leak. After gastrectomy (GE) its administration reduces the time of recovery of bowel motor function and the duration of hospitalization. After distal GE delay of gastric emptying may occur. In patients with SM, early start of enteral nutrition should be considered. After discharge from the hospital ONS can decelerate the progression of malnutrition, improve the tolerance of adjuvant chemotherapy and improve the quality of life. These effects are most clear after GE and in patients with a high risk of malnutrition (NRS‑2002 ≥ 3). There are no evident advantages of any particular type of ONS in patients with GC. When choosing a specific product, preference should be given to formulas with optimal nitrogen: non‑protein kilocalories ratio, osmolarity closest to physiological and individually selected organoleptic properties. It is recommended that the patient consume at least 200–250 ml of the mixture per day, and in the early postoperative period focus have to be made not on the target volume, but on signs of tolerability.
About the Authors
A. L. PotapovRussian Federation
Aleksandr L. Potapov – Dr. Sci. (Med.), head of the anesthesiology and resuscitation department
SPIN: 9189-4126, AuthorID: 717996
4 Korolev str., Obninsk 249036
V. E. Khoronenko
Russian Federation
Viktoriya E. Khoronenko – Dr. Sci. (Med.), associate lecturer, head of the anesthesiology and resuscitation department
SPIN: 1971-6546, AuthorID: 467560
3 2nd Botkinskiy travel, Moscow 125284
E. V. Gameeva
Russian Federation
Elena V. Gameeva – Cand. Sci. (Med.), deputy director for medical work
SPIN: 9423-7155, AuthorID: 294656,
Scopus AuthorID: 6504612323, ResearcherID: AAD-3025-2020
3 2nd Botkinskiy travel, Moscow 125284
Zh. V. Khailova
Russian Federation
Zhanna V. Khailova – Cand. Sci. (Med.), head physician
4 Korolev str., Obninsk 249036
A. D. Dorozhkin
Russian Federation
Artem D. Dorozhkin – anesthesiologist-resuscitator
SPIN: 3189-4950, AuthorID: 1037700
4 Korolev str., Obninsk 249036
V. Yu. Scoropad
Russian Federation
Vitaliy Yu. Skoropad – Dr. Sci. (Med.), senior researcher
SPIN: 2283-1111, AuthorID: 213297, Researcher ID: E-2200-2018
4 Korolev str., Obninsk 249036
References
1. Kuwada K, Kuroda S, Kikuchi S, Yoshida R, Nishizaki M, Kagawa S, et al. Clinical Impact of Sarcopenia on Gastric Cancer. Anticancer Res. 2019 May;39(5):2241–2249. https://doi.org/10.21873/anticanres.13340
2. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017 Jun;36(3):623–650. https://doi.org/10.1016/j.clnu.2017.02.013
3. Lee Y, Yu J, Doumouras AG, Li J, Hong D. Enhanced recovery after surgery (ERAS) versus standard recovery for elective gastric cancer surgery: A meta-analysis of randomized controlled trials. Surg Oncol. 2020 Mar;32:75–87. https://doi.org/10.1016/j.suronc.2019.11.004
4. Wang L-H, Zhu R-F, Gao C, Wang S-L, Shen L-Z. Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis. World J Gastroenterol. 2018 Apr 14;24(14):1562– 1578. https://doi.org/10.3748/wjg.v24.i14.1562
5. Potapov AL, Khoronenko VE, Gameeva EV, Khailova ZhV, Boiarkina AV, Ivanov SA, et al. Oral nutrition supplements: applied classification of formulas and basic rules of their prescribing in oncology. Problems of Nutrition. 2020;89(1):69–76. (In Russian). https://doi.org/10.24411/0042-8833-2020-10008
6. Leyderman IN, Gritsan AI, Zabolotskikh IB, Lomidze SV, Mazurok VA, Nekhaev IV, et al. Perioperative nutritional support. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care. 2018;3:5–21. (In Russian). https://doi.org/10.21320/1818-474X-2018-3-5-21
7. Kong S-H, Lee H-J, Na J-R, Kim WG, Han D-S, Park S-H, et al. Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: A prospective randomized trial. Surgery. 2018 Dec;164(6):1263–1270. https://doi.org/10.1016/j.surg.2018.05.017
8. Sergienko AD, Khoronenko VE, Gameeva EV, Ryabov AB., Khomyakov VM. The effect of nutritional therapy on quality of life indicators for patients with gastric cancer at the stage of surgical treatment. Research and Practical Medicine Journal. 2019;6(3):108–114. (In Russian). https://doi.org/10.17709/2409-2231-2019-6-3-10
9. Chen X, Yang K, Zhang X, Li K. Meta-analysis of preoperative oral nutritional supplements for patients with gastric cancer: East Asian experience. Eur J Clin Nutr. 2020 Jul;74(7):991–1000. https://doi.org/10.1038/s41430-019-0483-0
10. Oh SE, Choi M-G, Seo J-M, An JY, Lee JH, Sohn TS, et al. Prognostic significance of perioperative nutritional parameters in patients with gastric cancer. Clin Nutr. 2019 Apr;38(2):870–876. https://doi.org/10.1016/j.clnu.2018.02.015
11. Yang Y, Gao P, Song Y, Sun J, Chen X, Zhao J, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis. Eur J Surg Oncol. 2016 Aug;42(8):1176–1182. https://doi.org/10.1016/j.ejso.2016.05.029
12. Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, et al. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy. Surg Today. 2017 Aug;47(8):1018–1026. https://doi.org/10.1007/s00595-017-1469-y
13. Bozzetti F. Chemotherapy-Induced Sarcopenia. Curr Treat Options Oncol. 2020 Jan 30;21(1):7. https://doi.org/10.1007/s11864-019-0691-9
14. Liu X, Wang D, Zheng L, Mou T, Liu H, Li G. Is early oral feeding after gastric cancer surgery feasible? A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2014;9(11):e112062. https://doi.org/10.1371/journal.pone.0112062
15. Willcutts KF, Chung MC, Erenberg CL, Finn KL, Schirmer BD, Byham-Gray LD. Early Oral Feeding as Compared with Traditional Timing of Oral Feeding After Upper Gastrointestinal Surgery: A Systematic Review and Meta-analysis. Ann Surg. 2016 Jul;264(1):54–63. https://doi.org/10.1097/SLA.0000000000001644
16. Nakaseko Y, Ohdaira H, Yoshida M, Kitajima M, Suzuki Y. Clinical pathway after gastrectomy for gastric cancer: A case series of laparoscopic gastrectomy and early oral intake with "iEatTM." Ann Med Surg (Lond). 2018 Jul;31:20–24. https://doi.org/10.1016/j.amsu.2018.03.023
17. Shimizu N, Oki E, Tanizawa Y, Suzuki Y, Aikou S, Kunisaki C, et al. Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial. Surg Today. 2018 Sep;48(9):865– 874. https://doi.org/10.1007/s00595-018-1665-4
18. Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, et al. Patterns and Predictors of Weight Loss After Gastrectomy for Cancer. Ann Surg Oncol. 2016 May;23(5):1639–1645. https://doi.org/10.1245/s10434-015-5065-3
19. Kobayashi D, Ishigure K, Mochizuki Y, Nakayama H, Sakai M, Ito S, et al. Multi-institutional prospective feasibility study to explore tolerability and efficacy of oral nutritional supplements for patients with gastric cancer undergoing gastrectomy (CCOG1301). Gastric Cancer. 2017 Jul;20(4):718–727. https://doi.org/10.1007/s10120-016-0668-3
20. Hatao F, Chen K-Y, Wu J-M, Wang M-Y, Aikou S, Onoyama H, et al. Randomized controlled clinical trial assessing the effects of oral nutritional supplements in postoperative gastric cancer patients. Langenbecks Arch Surg. 2017 Mar;402(2):203–211. https://doi.org/10.1007/s00423-016-1527-8
21. Meng Q, Tan S, Jiang Y, Han J, Xi Q, Zhuang Q, et al. Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: A randomized clinical trial. Clin Nutr. 2021 Jan;40(1):40–46. https://doi.org/10.1016/j.clnu.2020.04.043
22. Cheng Y, Zhang J, Zhang L, Wu J, Zhan Z. Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis. BMC Gastroenterol. 2018 Jan 16;18(1):11. https://doi.org/10.1186/s12876-018-0741-y
23. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015
24. Ida S, Hiki N, Cho H, Sakamaki K, Ito S, Fujitani K, et al. Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Br J Surg. 2017 Mar;104(4):377–383. https://doi.org/10.1002/bjs.10417
25. Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, et al. Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020 Aug;38:28–42. https://doi.org/10.1016/j.clnesp.2020.05.007
26. Kostyuchenko AL, Kostin ED, Kurygin AA. Entheral artificial nutrition in intensive medicine. Saint-Petersburg: "Special'naya literatura", 1996, 330 p. (In Russian).
27. Lidoriki I, Schizas D, Mylonas KS, Frountzas M, Mastoraki A, Pikoulis E, et al. Oral Nutritional Supplementation Following Upper Gastrointestinal Cancer Surgery: A Prospective Analysis Exploring Potential Barriers to Compliance. J Am Coll Nutr. 2020 Oct;39(7):650–656. https://doi.org/10.1080/07315724.2020.1723453
Review
For citations:
Potapov A.L., Khoronenko V.E., Gameeva E.V., Khailova Zh.V., Dorozhkin A.D., Scoropad V.Yu. Oral nutritional supplements for gastric cancer – the review of current evidence. Research and Practical Medicine Journal. 2021;8(1):53-61. (In Russ.) https://doi.org/10.17709/2409-2231-2021-8-1-5